Skip to main content

Jeanne Bertonis, MBA, M.S.

Jeanne Bertonis, MBA, M.S.

Principal Partner, Strategic Biomedical Consultants
Image
Jeanne Bertonis.jpg

Jeanne Bertonis is a seasoned healthcare professional with experience in early stage start-up companies as well as established multinational corporations. For the past 15 years she has been providing strategic and business consulting to pharmaceutical, medical device, AI, regenerative medicine, biomaterial and diagnostic companies. Projects range from the creation of business, product and marketing strategies, to licensing, partnering, and mergers and acquisitions. Bertonis has an MBA from the Kellogg School of Management, an MS from University of Massachusetts, and a BA from Vassar College. She has served as Director for both private and public biotech and device companies. 

From 2019 to 2022 she served as COO for Azitra, Inc,, a clinical-stage dermatology company. Bertonis was the co-founder and CEO of Visgo Therapeutics from 2013 to 2018, Visgo focused on local drug therapies for joint diseases. She was President and CEO of BioSyntech, a public biomaterials company with an approved product for cartilage repair, from 2009 to 2010. From 2000-2006, she held the positions of Chief Business Officer and Vice President Corporate Development for Angiotech Pharmaceuticals, the company that developed the paclitaxel-coated stent. Bertonis has additional experience in business and research positions with Genzyme, Guidant, Eli Lilly and Biogen.